CBD has become one of the most sought-after cosmetic ingredients — but regulatory complexity stops many brands in their tracks. This guide covers everything you need to know to launch legally in the EU.
What Is CBD in Cosmetics?
Cannabidiol (CBD) is a naturally occurring compound found in the Cannabis sativa plant. Unlike THC, CBD does not produce psychoactive effects. In cosmetics, it is prized for its anti-inflammatory, antioxidant, and skin-calming properties — making it a popular addition to serums, creams, and scalp treatments.
The global CBD skincare market has grown rapidly, driven by consumer interest in natural and functional ingredients. However, brands must navigate a complex regulatory landscape that varies by source material, extraction method, and target market.
Understanding the difference between CBD isolate, broad-spectrum CBD, and full-spectrum hemp extract is essential before formulating. Each has different regulatory implications under EU law, and your choice will directly impact your Cosmetic Product Safety Report (CPSR) and labelling requirements.
EU Legal Status: What You Can and Cannot Do
Under the EU Cosmetics Regulation 1223/2009, CBD derived from hemp (Cannabis sativa L.) with less than 0.2% THC is not listed as a prohibited or restricted substance. However, the source and extraction method matter enormously.
Synthetic CBD is permitted for use in cosmetics without restriction, as it does not fall under the Novel Food or narcotics frameworks. Naturally derived CBD, however, requires careful consideration of its source plant part and extraction process.
The European Commission's CosIng database lists several hemp-derived ingredients as permitted in cosmetics, including Cannabis Sativa Seed Oil, Cannabis Sativa Leaf Extract, and Cannabidiol itself. However, ingredients derived from the flowering tops of the plant may face additional scrutiny depending on member state interpretations.
Important Note: CBD products derived from flowers and leaves are subject to stricter scrutiny in some EU member states. Always verify country-specific regulations in addition to EU-wide rules. France, for example, has historically taken a more restrictive stance on hemp flower extracts.
The THC threshold is critical. Any cosmetic product containing detectable THC above 0.2% could be classified as a controlled substance in many EU jurisdictions. Brands must ensure their supply chain includes Certificate of Analysis (CoA) documentation confirming THC levels for every batch of CBD raw material.
Permitted Hemp Ingredients
The CosIng database recognises several hemp-derived cosmetic ingredients. Understanding which are permitted — and under what conditions — is the foundation of a compliant CBD cosmetics strategy.
Cannabis Sativa Seed Oil is the most widely accepted hemp ingredient. Cold-pressed from hemp seeds, it contains no CBD or THC and is rich in omega fatty acids. It is used as an emollient and skin-conditioning agent with no regulatory restrictions.
Cannabis Sativa Leaf Extract is derived from the leaves of the hemp plant and may contain trace amounts of cannabinoids. It is listed in CosIng and permitted for cosmetic use, though brands should verify cannabinoid content through lab testing.
Cannabidiol (CBD) itself is listed in CosIng with the function of skin conditioning. When sourced from permitted plant parts (seeds, stems, leaves) and containing less than 0.2% THC, it can be used in cosmetic formulations across the EU.
Brands should work closely with their manufacturing laboratory to ensure all hemp-derived ingredients are properly sourced, documented, and tested before incorporation into finished products.
Need Help With CBD Cosmetics Compliance?
MySwissLab offers full safety assessment services for CBD cosmetic products, including CPSR preparation, ingredient verification, and regulatory guidance. Turnaround: 5 to 10 business days.
Learn MoreLabeling Requirements
CBD cosmetic products must comply with the same labelling requirements as all other cosmetics under Regulation 1223/2009. However, several elements require special attention when cannabinoid ingredients are involved.
The INCI name for CBD is simply "Cannabidiol" and must appear in the ingredient list in descending order of concentration. If CBD is present at less than 1% of the total formula, it may be listed in any order after all ingredients above 1%.
The Responsible Person's name and address must appear on the product label. For non-EU brands importing CBD cosmetics into the EU, appointing a Responsible Person established within the EU or EEA is mandatory.
Product claims must be substantiated and must not imply therapeutic benefits. Terms like "pain relief," "anti-anxiety," or "treats eczema" are considered medicinal claims and are prohibited on cosmetic products. Instead, brands should focus on cosmetic claims such as "soothes skin," "calms irritation," or "antioxidant protection."
The PAO (Period After Opening) symbol is required for CBD products with a shelf life exceeding 30 months. Stability testing is particularly important for CBD formulations, as cannabinoids can degrade when exposed to light, heat, or oxygen.
CPSR for CBD Products
Every cosmetic product placed on the EU market requires a Cosmetic Product Safety Report (CPSR), and CBD products are no exception. In fact, the CPSR for CBD cosmetics requires additional documentation compared to standard formulations.
The safety assessor will evaluate the toxicological profile of all CBD and hemp-derived ingredients, including potential contaminants such as heavy metals, pesticides, and residual solvents from the extraction process. A Certificate of Analysis from the raw material supplier is essential.
The CPSR must include stability data demonstrating that the CBD content remains consistent throughout the product's shelf life. Degradation of cannabinoids can produce unwanted by-products that must be assessed for safety.
Microbiological testing is also critical, particularly for water-based CBD formulations. The challenge test (preservative efficacy test) must demonstrate that the preservation system is effective in the presence of hemp-derived ingredients, which can sometimes interfere with preservative performance.
At MySwissLab, our qualified safety assessors have extensive experience preparing CPSRs for CBD cosmetic products. We work with your ingredient suppliers to gather all necessary documentation, conduct required testing, and deliver a compliant safety report.
Marketing Claims
Marketing CBD cosmetics requires a careful balance between highlighting the ingredient's benefits and staying within the boundaries of cosmetic claims regulation. The EU Common Criteria for cosmetic claims (Regulation 655/2013) apply to all CBD product marketing.
Claims must be truthful, supported by evidence, and not mislead consumers. Any claim that implies a therapeutic or medicinal benefit will reclassify your product as a medicinal product, subjecting it to an entirely different (and far more expensive) regulatory framework.
Permitted cosmetic claims for CBD products include: "soothes and calms skin," "helps maintain skin's natural balance," "antioxidant skincare," "nourishing formula with hemp-derived CBD," and "supports skin comfort."
Prohibited claims include: "treats acne," "reduces pain," "anti-inflammatory treatment," "cures skin conditions," and any reference to medical or therapeutic outcomes.
Brands should also be cautious about environmental or sustainability claims related to hemp cultivation. Any such claims must be substantiated with verifiable evidence under the EU Green Claims Directive.
Ready to Launch Your CBD Cosmetic Line?
From formulation to compliance documentation, MySwissLab provides end-to-end support for CBD cosmetic brands entering the EU market.
Get a Quote
